AJR Am J Roentgenol

1. KEUNG JJ
   Editorial Comment: Leveling the Playing Field in Percutaneous Cryoablation of Lung Tumors Using High-Frequency Jet Ventilation.
   AJR Am J Roentgenol. 2024;222:e2430972.
   

   >> Share

   
   
2. GRAUR A, Mercaldo ND, Simon J, Alici C, et al
   High-Frequency Jet Ventilation Versus Spontaneous Respiration for Percutaneous Cryoablation of Lung Tumors: Comparison of Adverse Events and Procedural Efficiency.
   AJR Am J Roentgenol. 2024;222:e2330557.
   

   >> Share

   
   

   
   Am J Clin Oncol

3. ZHANG T, Hu Y, Yang N, Yu S, et al
   The microRNA-34 Family and Its Functional Role in Lung Cancer.
   Am J Clin Oncol. 2024 May 3. doi: 10.1097/COC.0000000000001106.
   

   >> Share

   
   

   
   Ann Oncol

4. YU HA, Baik C, Kim DW, Johnson ML, et al
   Translational insights and overall survival in the U31402-A-U102 study of patritumab deruxtecan (HER3-DXd) in EGFR-mutated NSCLC.
   Ann Oncol. 2024;35:437-447.
   

   >> Share

   
   
5. SCOTT S, Levy B
   New ADCs bring new questions in EGFR NSCLC and beyond.
   Ann Oncol. 2024;35:412-413.
   

   >> Share

   
   

   
   Ann Surg Oncol

6. SIRAKAYA F, Calik Kutukcu E, Onur MR, Dikmen E, et al
   The Effects of Various Approaches to Lobectomies on Respiratory Muscle Strength, Diaphragm Thickness, and Exercise Capacity in Lung Cancer.
   Ann Surg Oncol. 2024 Apr 28. doi: 10.1245/s10434-024-15312.
   

   >> Share

   
   

   
   Anticancer Res

7. CHEN LH, Tsai YF, Wu WT, Chiu KL, et al
   Association of Matrix Metalloproteinase-9 Genotypes With Lung Cancer Risk in Taiwan.
   Anticancer Res. 2024;44:1845-1852.
   

   >> Share

   
   
8. RADES D, Cremers F, Janssen S, Bartscht T, et al
   Associations Between Mean Lung Dose and Prevalence of Radiation Pneumonitis in Elderly Lung Cancer Patients.
   Anticancer Res. 2024;44:2073-2079.
   

   >> Share

   
   
9. CHOI YJ, Chung YH, Lee K, Jeong M, et al
   SH003 Enhances the Anti-cancer Effects of Dabrafenib on Lung Cancer Harboring BRAF G469A Mutation by Inhibiting the MAPK Signaling Pathway.
   Anticancer Res. 2024;44:1905-1913.
   

   >> Share

   
   
10. JI N, Lee Y, Lee SH, Kim HS, et al
    Diagnostic Value of Immunostaining for Thyroid Transcription Factor 1 (TTF1) and Paired Box 8 (PAX8) in Distinguishing Pulmonary Metastases of Mesonephric and Mesonephric-like Adenocarcinomas from Primary Lung Adenocarcinomas.
    Anticancer Res. 2024;44:2159-2170.
    

    >> Share

    
    
11. CHARPIDOU A, Mani M, Kokkotou E, Stournara L, et al
    Molecular Diagnostics and Treatment Patterns in Metastatic Non-small Cell Lung Cancer Patients: Real World Evidence from Greece: LACHESIS Study.
    Anticancer Res. 2024;44:2063-2072.
    

    >> Share

    
    
12. KOH YW, Han JH, Haam S, Lee HW, et al
    Prediction of Responsiveness to PD-L1/PD-1 Inhibitors Using miRNA Profiles Associated With PD-L1 Expression in Lung Adenocarcinoma and Squamous Cell Carcinoma.
    Anticancer Res. 2024;44:2081-2089.
    

    >> Share

    
    
13. SOLIS-ESTRADA J, Arredondo-Espinoza E, Pioquinto-Avila E, Gonzalez-Cruz AO, et al
    Design and Evaluation of a Humanized Anti-EGFR huscFv Antibody Fragment in Combination With Metformin in A549 Cells In Vitro.
    Anticancer Res. 2024;44:1955-1962.
    

    >> Share

    
    

    
    BMC Cancer

14. HE M, Jiang W, Li X, Liu H, et al
    25-hydroxycholesterol promotes proliferation and metastasis of lung adenocarcinoma cells by regulating ERbeta/TNFRSF17 axis.
    BMC Cancer. 2024;24:505.
    

    >> Share

    
    
15. LI Y, Gong B, Guo Y, Liu W, et al
    Non-small cell lung cancer and immune checkpoint inhibitor therapy: does non-alcoholic fatty liver disease have an effect?
    BMC Cancer. 2024;24:535.
    

    >> Share

    
    
16. DENG Z, Liu X, Wu R, Yan H, et al
    Ultrasound-based radiomics machine learning models for diagnosing cervical lymph node metastasis in patients with non-small cell lung cancer: a multicentre study.
    BMC Cancer. 2024;24:536.
    

    >> Share

    
    
17. VIANA VELOSO GG, Amaral FD, Nogueira-Rodrigues A
    Impact of COVID-19 pandemic among patients with lung and head and neck cancer assisted in a public cancer center in Brazil.
    BMC Cancer. 2024;24:539.
    

    >> Share

    
    
18. CUNNINGHAM R, Stanley J, Imlach F, Haitana T, et al
    Cancer diagnosis after emergency presentations in people with mental health and substance use conditions: a national cohort study.
    BMC Cancer. 2024;24:546.
    

    >> Share

    
    

    
    Cancer Lett

19. SUN BB, Wang GZ, Han SC, Yang FY, et al
    Oncogenic functions and therapeutic potentials of targeted inhibition of SMARCAL1 in small cell lung cancer.
    Cancer Lett. 2024 Apr 30:216929. doi: 10.1016/j.canlet.2024.216929.
    

    >> Share

    
    

    
    Cancer Res

20. XIANG H, Pan Y, Sze MA, Wlodarska M, et al
    Single-Cell Analysis Identifies NOTCH3-Mediated Interactions between Stromal Cells That Promote Microenvironment Remodeling and Invasion in Lung Adenocarcinoma.
    Cancer Res. 2024;84:1410-1425.
    

    >> Share

    
    
21. PARK SJ, Ju S, Goh SH, Yoon BH, et al
    Proteogenomic Characterization Reveals Estrogen Signaling as a Target for Never-Smoker Lung Adenocarcinoma Patients without EGFR or ALK Alterations.
    Cancer Res. 2024;84:1491-1503.
    

    >> Share

    
    

    
    Cancer Sci

22. ZHANG C, Sun N, Fei Q, Peng L, et al
    MEN1 deficiency stabilizes PD-L1 and promotes tumor immune evasion of lung cancer.
    Cancer Sci. 2024 Apr 30. doi: 10.1111/cas.16196.
    

    >> Share

    
    
23. OTANI Y, Katayama H, Zhu Y, Huang R, et al
    Adrenergic microenvironment driven by cancer-associated Schwann cells contributes to chemoresistance in patients with lung cancer.
    Cancer Sci. 2024 Apr 27. doi: 10.1111/cas.16164.
    

    >> Share

    
    

    
    Clin Cancer Res

24. REKHTMAN N
    All That Is Small Is Not a Small-Cell Carcinoma: Thoracic SMARCA4-Deficient Undifferentiated Tumors Masquerading as SCLC.
    Clin Cancer Res. 2024;30:1708-1711.
    

    >> Share

    
    
25. MARINIELLO A, Nasti TH, Chang DY, Hashimoto M, et al
    Platinum-Based Chemotherapy Attenuates the Effector Response of CD8 T Cells to Concomitant PD-1 Blockade.
    Clin Cancer Res. 2024;30:1833-1845.
    

    >> Share

    
    

    
    Clin Lung Cancer

26. NILSSEN Y, Brustugun OT, Fjellbirkeland L, Gronberg BH, et al
    Small Cell Lung Cancer in Norway: Patterns of Care by Health Region and Survival Trends.
    Clin Lung Cancer. 2024 Apr 10:S1525-7304(24)00046.
    

    >> Share

    
    

    
    Eur J Cardiothorac Surg

27. HENSCHKE P, Guglielmetti LC, Hillinger S, Monsch GM, et al
    Risk factors influencing postoperative pleural empyema in patients with pleural mesothelioma: a retrospective single-centre analysis.
    Eur J Cardiothorac Surg. 2024;65:ezae137.
    

    >> Share

    
    

    
    J Cancer Res Clin Oncol

28. CHEN Q, Cheng J, Wang L, Lv X, et al
    Primary lung cancer in children and adolescents.
    J Cancer Res Clin Oncol. 2024;150:225.
    

    >> Share

    
    
29. MENG X, Peng F, Yu S, Chi X, et al
    Knockdown of NADK promotes LUAD ferroptosis via NADPH/FSP1 axis.
    J Cancer Res Clin Oncol. 2024;150:228.
    

    >> Share

    
    

    
    J Clin Invest

30. VACCARO K, Allen J, Whitfield TW, Maoz A, et al
    Targeted therapies prime oncogene-driven lung cancers for macrophage-mediated destruction.
    J Clin Invest. 2024;134:e169315.
    

    >> Share

    
    
31. MILLS GB, Labrie M
    Enhancing anticancer activity of macrophages through rational drug combinations.
    J Clin Invest. 2024;134:e180512.
    

    >> Share

    
    

    
    J Comput Assist Tomogr

32. KIRIKI M, Koizumi M, Maeda K, Sakai T, et al
    Development of the Split-Bolus Pulmonary Arteriovenous Separating Computed Tomography Angiography Protocol Based on Time Enhancement Curve for Lung Cancer Surgery.
    J Comput Assist Tomogr. 2024 May 2. doi: 10.1097/RCT.0000000000001621.
    

    >> Share

    
    

    
    J Nucl Med

33. WANG Y, Abdelhafez YG, Spencer BA, Verma R, et al
    High-Temporal-Resolution Kinetic Modeling of Lung Tumors with Dual-Blood Input Function Using Total-Body Dynamic PET.
    J Nucl Med. 2024 Mar 28:jnumed.123.267036. doi: 10.2967/jnumed.123.267036.
    

    >> Share

    
    

    
    Lancet Oncol

34. BURKI T
    EPA ruling to ban chrysotile asbestos.
    Lancet Oncol. 2024;25:537.
    

    >> Share

    
    

    
    Mol Cancer Ther

35. XU Y, Ding K, Peng Z, Ding L, et al
    Evaluating for Correlations between Specific Metabolites in Patients Receiving First-Line or Second-Line Immunotherapy for Metastatic or Recurrent NSCLC: An Exploratory Study Based on Two Cohorts.
    Mol Cancer Ther. 2024;23:733-742.
    

    >> Share

    
    
36. MA W, Wei S, Li Q, Zeng J, et al
    Simvastatin Overcomes Resistance to Tyrosine Kinase Inhibitors in Patient-derived, Oncogene-driven Lung Adenocarcinoma Models.
    Mol Cancer Ther. 2024;23:700-710.
    

    >> Share

    
    

    
    Nat Med

37. SCHULER M, Cuppens K, Plones T, Wiesweg M, et al
    Neoadjuvant nivolumab with or without relatlimab in resectable non-small-cell lung cancer: a randomized phase 2 trial.
    Nat Med. 2024 Apr 30. doi: 10.1038/s41591-024-02965.
    

    >> Share

    
    

    
    Oncologist

38. VALLEJO J, Singh H, Larkins E, Drezner N, et al
    Impact of Increasing PD-L1 Levels on Outcomes to PD-1/PD-L1 Inhibition in Patients With NSCLC: A Pooled Analysis of 11 Prospective Clinical Trials.
    Oncologist. 2024;29:422-430.
    

    >> Share

    
    

    
    PLoS One

39. ZHANG MS, Yeh YC, Huang HN, Lin LW, et al
    The association of EGFR amplification with aberrant exon 20 insertion report using the cobas EGFR Mutation Test v2.
    PLoS One. 2024;19:e0301120.
    

    >> Share

    
    
40. KONG Y, Hong L, Xu XC, Chen YF, et al
    The relative risk of immune checkpoint inhibitor pneumonitis in advanced non-small- cell lung cancer: Meta-analyses of controlled clinical trials.
    PLoS One. 2024;19:e0301931.
    

    >> Share

    
    
41. WU B, Zhang X, Feng N, Hu Z, et al
    Treatment strategies for stage IA non-small cell lung cancer: A SEER-based population study.
    PLoS One. 2024;19:e0298470.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

42. DONG Z, Wang Y, Xu G, Liu B, et al
    Genetic and phenotypic profiling of single living circulating tumor cells from patients with microfluidics.
    Proc Natl Acad Sci U S A. 2024;121:e2315168121.
    

    >> Share

    
    
43. DUTT P, Haider N, Mouaaz S, Podmore L, et al
    beta-catenin turnover is regulated by Nek10-mediated tyrosine phosphorylation in A549 lung adenocarcinoma cells.
    Proc Natl Acad Sci U S A. 2024;121:e2300606121.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share